The trading session has ended on a higher note as the Dow Jones Industrial Average finished at 16,569.98, up 0.10% and the NASDAQ Composite closed at 4,401.33, up 0.70%. The S&P 500 finished the day 0.28% higher at 1,936.92. During the trading session seven out of ten sectors finished on a positive note. The S&P 500 Health Care Sector Index finished the day at 700.04, up 0.01%, and the index has advanced 4.74% in the previous three months. We have in this article covered the following equities: Medivation Inc (NASDAQ MDVN), Ironwood Pharmaceuticals Inc (NASDAQ IRWD), Momenta Pharmaceuticals Inc (NASDAQ MNTA), Galectin Therapeutics Inc (NASDAQ GALT) and PDL BioPharma Inc (NASDAQ PDLI).
Medivation Inc.’s stock of 1.19 million shares were traded, above its three months average volume of 0.94 million shares. Shares in Medivation Inc. have gained 8.81% in the previous three trading sessions and 10.99% in the last one month. Moreover, the company’s shares have surged 30.45% from the beginning of 2014.
The company’s stock is trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $75.69 is above its 200-day moving average of $69.36. Further, Medivation Inc.’s stock traded at a PE ratio of 308.33 and has a Relative Strength Index (RSI) of 63.28.
Biotech Stock News
Shares in Ironwood Pharmaceuticals Inc recorded a trading volume of 0.75 million shares, which was below its three months average volume of 1.35 million shares. Shares in Ironwood Pharmaceuticals Inc. have fallen by 3.88% in the previous three trading sessions and 9.83% in the last one month, while the company’s shares have advanced 15.33% since the start of this year. Shares in Ironwood Pharmaceuticals Inc are trading below their 50-day moving average. The stock’s 50-day moving average of $14.62 is above its 200-day moving average of $12.78. Additionally, the stock has an RSI of 40.73.
Momenta Pharmaceuticals Inc.’s stock recorded a trading volume of 0.32 million shares, below its three months average volume of 0.59 million shares. Shares in Momenta Pharmaceuticals Inc have advanced 3.36% in the previous three trading sessions. However, the company’s shares are down 2.90% in the last one month and 35.58% on YTD basis. Shares in Momenta Pharmaceuticals Inc. are trading below their 50-day and 200-day moving averages of $11.85 and $14.59, respectively. Furthermore, the stock has an RSI of 47.39.
Biotech News Video
Watch this video for more “Biotech” news.
Biotech Financial News
Stay tuned to Technews for all the updates about various biotech stocks in the market. All the news and market movement of biotech stocks will be reported by Technews regularly.
Thanks for visiting the TechNews.org website. Be sure to catch all BioTech financial news, bookmark us and check all the videos and news articles regarding Biotech business news.